BARD SINGULAR BIOPSY FORCEPS— 510(k) K912214

Substantially Equivalent

C.R. Bard, Inc.

FDA 510(k) clearance K912214 for BARD SINGULAR BIOPSY FORCEPS, Substantially Equivalent on 1991-05-30. Applicant: C.R. Bard, Inc..

Clearance details

Applicant: C.R. Bard, Inc.
Product code: Code FCL
Advisory panel: Gastroenterology, Urology
Date received: 1991-05-20
Decision date: 1991-05-30
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Tewksbury, MA, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code FCL

product code FCL

Death: 5
Total: 5

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.